ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: FISH, cytogenetics/CMA, PCR and targeted panel‐based DNA‐sequencing qPCR/dPCR.for BCR::ABL1 monitoring. Sanger sequencing/NGS for ABL1 kinase domain mutation analysis in patients with CML JAK2p.V617F. CALR indels, MPLW515L/K mutations can be detected using PCR and capillary electrophoresis